Conclusion
Itraconazole was comparable to Methylprednisolone in preventing disease
recurrence in the post-operative management of AFRS. It may be a viable
alternative to replacing systemic steroids where the latter may be
contraindicated. Itraconazole given at a dose of 400 mg once daily for
six weeks was a safe dose.
Keywords : Allergic Fungal Rhinosinusitis, Itraconazole,
endoscopy, Quality of Life, Methylprednisolone
Key points :
- Itraconazole was comparable to systemic steroid (Methylprednisolone)
in preventing disease recurrence in the post-operative management of
AFRS.
- It may be a viable alternative to replacing systemic steroids where
the latter may be contraindicated.
- Itraconazole given at a dose of 400 mg once daily for six weeks was a
safe dose.
- Recurrence may be treated safely with Itraconazole than with steroids.
- The course may be repeated in case of recurrence with close
monitoring.